Creative Edge Nutrition, Inc. (FITX) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerCreative Edge Nutrition, Inc. (FITX) trades at $0.00001. Creative Edge Nutrition, Inc. develops and sells health-oriented nutrition products across categories like weight loss, metabolic enhancement, and muscle stimulation. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for FITX: FITX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Creative Edge Nutrition, Inc. (FITX) Healthcare & Pipeline Overview
Creative Edge Nutrition, Inc. is a Michigan-based developer and seller of health-oriented nutrition products, focusing on categories like weight loss, metabolic enhancement, and recovery. Operating in the specialty and generic drug manufacturers industry, the company offers a diverse product portfolio including MetaBolic Xtreme and Hyper-Infusion, catering to various wellness and performance needs.
What Is the Investment Thesis for FITX?
Creative Edge Nutrition, Inc. operates in the health-oriented nutrition market, offering a diverse product line spanning weight loss, metabolic enhancement, and muscle recovery. The company's reported gross margin of 80.3% indicates strong product-level profitability, suggesting efficient cost management in its core offerings. However, this is offset by a significant negative profit margin of -82.7% and negative free cash flow of $-0.00B, reflecting substantial operational expenses relative to revenue. The company's market capitalization is $0.00B, highlighting its micro-cap status and the inherent volatility associated with such small entities, further evidenced by a Beta of -0.53. Potential value drivers could emerge from strategic expansion within its niche markets, particularly if it can leverage its high gross margins to achieve profitability. Growth catalysts might include successful new product introductions in high-demand segments like natural supplements or functional foods, or improved market penetration for existing products such as MetaBolic Xtreme or Hemp Nutra Tea. Given its small employee base, operational efficiency and targeted marketing will be crucial. Risks include intense competition in the nutrition supplement industry, regulatory changes, and the challenge of scaling operations from its current micro-cap status to achieve sustainable positive free cash flow and profit margins.
Based on FMP financials and quantitative analysis
FITX Key Highlights
Gross margin of 80.3% indicates strong product-level profitability for its health-oriented nutrition products.
- Profit margin of -82.7% reflects significant operational expenses relative to revenue, leading to net losses.
- Negative free cash flow of $-0.00B suggests ongoing cash burn from operations, requiring external funding or improved profitability.
- Market capitalization of $0.00B positions the company as a micro-cap entity, often associated with higher risk and volatility.
- Beta of -0.53 indicates a low correlation with broader market movements, which can be characteristic of micro-cap stocks with limited trading activity.
Who Are FITX's Competitors?
FITX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| POM Pomdoctor Limited | $0.93 | +8.13% | $6.30M | — |
| MEDS TRxADE HEALTH, Inc. | $3.35 | -8.97% | $8.79M | — |
| MSLE Satellos Bioscience Inc. Common Stock | $8.50 | -0.12% | $11.0M | — |
| NEUP Neuphoria Therapeutics Inc. | $3.45 | -0.58% | $18.7M | — |
| AIXC AIxCrypto Holdings, Inc. | $1.01 | -39.16% | $20.4M | — |
| RNTX Rein Therapeutics, Inc. | $0.80 | -6.03% | $22.4M | — |
| KYNB Kyntra Bio, Inc. | $6.09 | -3.49% | $24.7M | — |
| YI 111, Inc. | $3.22 | -2.57% | $28.1M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FITX's Key Strengths?
High gross margin of 80.3% on product sales, indicating strong unit economics.
- Diversified product portfolio addressing multiple health categories, from weight loss to muscle enhancement.
- Established brand names for key products within its niche markets.
- Lean operational structure with 3 employees, potentially allowing for efficiency and flexibility.
What Are FITX's Weaknesses?
Significant negative profit margin of -82.7%, indicating substantial operational losses.
- Negative free cash flow of $-0.00B, suggesting ongoing cash burn.
- Micro-cap market capitalization of $0.00B, implying limited scale and potential for volatility.
- "Unknown" disclosure status on the OTC market, hindering investor transparency and due diligence.
What Are the Key Risks for FITX?
Financial-distress signal — its Altman Z-Score of -8.20 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Persistent negative profit margin of -82.7% and negative free cash flow, indicating challenges in achieving sustainable profitability.
- Intense competition within the health-oriented nutrition products market from larger, more established companies.
- The "Unknown" disclosure status on the OTC market, which limits investor access to critical financial and operational information.
- Regulatory changes or increased scrutiny in the supplement and natural products industry could impact product development and sales.
- Challenges associated with operating as a micro-cap company with a $0.00B market cap, including limited access to capital and low liquidity.
What Threats Does FITX Face?
- Intense competition from larger, well-funded players in the highly saturated nutrition supplement industry.
- Potential for adverse regulatory changes or increased scrutiny in the health and wellness product market.
- Challenges in scaling operations and achieving sustainable profitability from its current micro-cap status.
- Reliance on a small employee base, which could pose operational risks in terms of capacity and expertise.
What Are FITX's Competitive Advantages?
- Proprietary product formulations across its diverse range of health and nutrition categories.
- Established brand names for key products such as MetaBolic Xtreme, Hyper-Infusion, and Alpha-Drive.
- Niche market focus within the broader health and wellness industry, targeting specific consumer needs.
- Agile operational structure with a small employee base, potentially allowing for quick adaptation to market trends and product development.
What Does FITX Do?
Creative Edge Nutrition, Inc., headquartered in Madison Heights, Michigan, operates within the healthcare sector, specifically as a developer and seller of health-oriented nutrition products. The company, which was formerly known as Laufer Bridge Enterprises Inc. before changing its name to Creative Edge Nutrition, Inc. in April 2012, has established a portfolio designed to address various aspects of health and wellness. Its product offerings span several key categories, including weight loss, metabolic enhancement, recovery/well-being, muscle enhancement and stimulation, and a natural line. This diversified approach allows Creative Edge Nutrition to target a broad consumer base seeking nutritional support for different health objectives, from athletic performance to general wellness. Among its notable products, MetaBolic Xtreme is positioned for weight loss, aiming to support individuals in their body composition goals. Hyper-Infusion serves as a pre-workout powder, specifically formulated to enhance endurance and strength for athletes and fitness enthusiasts seeking to maximize their training output. For post-workout recovery and hormonal support, the company offers Alpha-Drive, a product designed for post cycle therapy, which caters to a niche segment within the muscle enhancement market. Amino Plex functions as an intra-workout recovery catalyst, emphasizing the importance of sustained performance and muscle repair during exercise, thereby supporting continuous physical activity. Beyond performance-focused supplements, Creative Edge Nutrition also addresses general health and well-being with products like Chia Plex, which leverages the nutritional benefits of chia seeds. Furthermore, the company has ventured into the natural beverage additive market with Hemp Nutra Tea and Nutra Coffee additives, indicating a strategic move towards incorporating natural ingredients into daily consumption habits and expanding its reach within the broader health food segment. With a lean operational structure supported by three employees, Creative Edge Nutrition, Inc. focuses on developing and marketing these specialized nutritional supplements to consumers across its established product categories.
What Products and Services Does FITX Offer?
- Develops and sells a portfolio of health-oriented nutrition products.
- Offers products for weight loss, including MetaBolic Xtreme.
- Provides supplements for metabolic enhancement.
- Markets recovery and well-being products, such as Chia Plex.
- Sells muscle enhancement and stimulation products like Hyper-Infusion and Alpha-Drive.
- Features a natural product line, including Hemp Nutra Tea and Nutra Coffee additives.
- Operates within the specialty and generic drug manufacturers industry.
- Based in Madison Heights, Michigan, with a small team of 3 employees.
How Does FITX Make Money?
- Generates revenue through the direct sale of its proprietary health-oriented nutrition supplements.
- Develops and formulates products across various health categories to address specific consumer needs.
- Likely utilizes e-commerce platforms and potentially wholesale distribution channels for product sales.
- Relies on product innovation and targeted marketing to drive consumer purchases and brand recognition.
What Industry Does FITX Operate In?
Creative Edge Nutrition, Inc. operates within the highly competitive and dynamic Drug Manufacturers - Specialty & Generic industry, specifically focusing on the health-oriented nutrition products segment. This market is characterized by evolving consumer preferences towards wellness, natural ingredients, and performance-enhancing supplements. The company's product categories, including weight loss, metabolic enhancement, and muscle recovery, align with significant market trends driven by increasing health consciousness and an aging global population seeking to maintain vitality. However, the industry also faces intense competition from established pharmaceutical companies, large consumer goods corporations, and numerous smaller, agile supplement brands. Creative Edge Nutrition, with its lean structure and specialized product lines like MetaBolic Xtreme and Hemp Nutra Tea, positions itself as a niche player aiming to capture specific segments of this broad market. Its ability to differentiate products and effectively market to its target demographic will be critical for navigating this crowded landscape.
Who Are FITX's Key Customers?
- Individuals seeking effective weight loss solutions and metabolic support.
- Athletes and fitness enthusiasts focused on enhancing performance, endurance, muscle growth, and recovery.
- Consumers interested in general health and well-being through natural supplements.
- Individuals looking for natural additives to incorporate into their daily beverages.
- Niche segments within the sports nutrition and wellness markets.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on assets is -69.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 15.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.34 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
Creative Edge Nutrition, Inc. operates in the Healthcare sector. It is headquartered in Madison Heights, US. FITX has traded publicly since 2010.
Financial Health
Creative Edge Nutrition, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -8.20 places it in the distress zone, a signal of elevated financial risk.
FITX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
FITX Latest News
-
Stocks That Hit 52-Week Lows On Thursday
· Jan 9, 2020
-
GNC Holdings Inc. Sinks On Expanded Industry Probe
· Mar 10, 2015
FITX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for FITX.
Price Targets
Wall Street price target analysis for FITX.
FITX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for FITX; grades run from A+ (80-100) to F (below 30).
Leadership: Paul R. Thomas
CEO
Paul R. Thomas serves as the leader of Creative Edge Nutrition, Inc., overseeing its operations and strategic direction. This suggests a hands-on leadership approach, crucial for a company operating with a small workforce in the specialized nutrition products sector. His role encompasses guiding the company's product development, market positioning, and overall business strategy within the competitive healthcare industry.
Track Record: Under Paul R. Thomas's leadership, Creative Edge Nutrition, Inc. has maintained a portfolio of health-oriented nutrition products across various categories including weight loss and muscle enhancement. The company continues to offer products such as MetaBolic Xtreme and Hyper-Infusion. His tenure has seen the company operate with a notable gross margin of 80.3%, indicating effective cost management at the product level. The strategic decision to diversify into natural line products like Hemp Nutra Tea also reflects an adaptation to evolving consumer trends.
FITX OTC Market Information
Creative Edge Nutrition, Inc. trades on the OTC market under the "OTC Other" tier. This tier typically includes companies that do not meet the disclosure or financial standards of higher OTC tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. Companies in the "OTC Other" category may not provide current financial information to OTC Markets Group, making it challenging for investors to access comprehensive data. Unlike companies on major exchanges that adhere to strict SEC reporting requirements, "OTC Other" companies have significantly fewer obligations, leading to reduced transparency and increased investor risk.
- OTC Tier: OTC Other
- Limited public information due to "Unknown" disclosure status, hindering informed investment decisions.
- Extremely low liquidity, leading to wide bid-ask spreads and difficulty in executing trades.
- Higher susceptibility to fraud and manipulation due to less regulatory oversight compared to major exchanges.
- Potential for significant price volatility due to low trading volume and small market capitalization.
- Difficulty in obtaining reliable valuation metrics without consistent financial reporting.
- Verify any available financial statements directly from the company or third-party sources.
- Research management's background and track record beyond provided data.
- Assess the competitive landscape and market position of its products independently.
- Investigate any news or press releases from reputable sources, if available.
- Understand the company's operational history and any past regulatory issues.
- Evaluate the current product portfolio and market demand for its specific offerings.
- Consider the potential for delisting or further deterioration of trading status.
- Identified CEO, Paul R. Thomas, managing the company's operations.
- Established headquarters in Madison Heights, Michigan, US, indicating a physical presence.
- Specific product names and categories are detailed in its business description, suggesting tangible offerings.
- History of name change from Laufer Bridge Enterprises Inc. in 2012, indicating some operational longevity.
What Investors Ask About Creative Edge Nutrition, Inc. (FITX) — Healthcare
Given its OTC status, what are the implications for investors in Creative Edge Nutrition, Inc.?
Investing in Creative Edge Nutrition, Inc. as an OTC "OTC Other" tier stock carries several implications. The "Unknown" disclosure status means investors have very limited access to current and comprehensive financial reports, making it difficult to perform thorough due diligence or accurately assess the company's valuation and performance.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.